Dermata Therapeutics reports improved skin appearance in Tome treatment study
DRMA•Dermata Therapeutics reported positive topline results from an open-label cosmetic study of its Tome Foundational Treatment. Among 31 participants using it weekly for four weeks, the treatment improved skin appearance, was well tolerated and had no reported treatment-related adverse events.
1. Study results
Dermata Therapeutics announced positive topline results from a completed open-label cosmetic study of its recently launched Tome Foundational Treatment. The 31 participants used the treatment once weekly for four weeks, with improvements in skin appearance; participants reported results comparable to professional in-office procedures, and no treatment-related adverse events were reported.
2. Treatment options
Tome Foundational Treatment is available as a one-time purchase of four weekly treatments or through a discounted subscription.
